Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SOLV Solventum | ABT Abbott Laboratories |
|---|---|---|
| Price | $88.84 +1.5% | $102.61 +0.4% |
| StockIQ Score | 58C Moderate Risk: High | 50C- Moderate Risk: Medium |
| Technical | 46D+ | 19F |
| Fundamental | 75B+ | 72B |
| Growth | 62C+ | 45D+ |
| Fair Value | 43D | 38F |
| News | 80A- | 98A+ |
| Quality | 58C | 63C+ |
| Risk | 42D | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Solventum (SOLV) outperforms Abbott Laboratories (ABT) in technical strength and investor sentiment, scoring 86 and 68 respectively, compared to ABT’s 50 and 54. Both share a "MODERATE" rating, but SOLV leads in growth (62 vs. 45) and valuation (43 vs. 38), while ABT slightly edges out in fundamentals (72 vs. 75). SOLV is stronger in most categories except fundamentals.